DAVID JORDEN - 04 Mar 2022 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
CEO/CFO, Director
Signature
/s/ David Jorden
Issuer symbol
AURX
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
26 Apr 2022, 21:29:41 UTC
Previous filing
26 Apr 2022
Next filing
02 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Option to Purchase Common Stock Award $0 +66,672 $0.000000 66,672 04 Mar 2022 Common Stock 66,672 $0.5000 Direct F1
transaction AURX Option to Purchase Common Stock Award $0 +125,000 $0.000000 125,000 04 Mar 2022 Common Stock 125,000 $0.7500 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019